192 related articles for article (PubMed ID: 15381193)
21. [AIDS vaccine].
Sikorska EJ
Pneumonol Alergol Pol; 1991; 59(3-4):146-52. PubMed ID: 1843911
[No Abstract] [Full Text] [Related]
22. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
23. HIV/AIDS: allied responses.
Mascola JR
Nature; 2007 Sep; 449(7158):29-30. PubMed ID: 17805280
[No Abstract] [Full Text] [Related]
24. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
van Gisbergen KP; Aarnoudse CA; Meijer GA; Geijtenbeek TB; van Kooyk Y
Cancer Res; 2005 Jul; 65(13):5935-44. PubMed ID: 15994972
[TBL] [Abstract][Full Text] [Related]
25. Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
Ahlers JD; Belyakov IM
Eur J Immunol; 2009 Oct; 39(10):2657-69. PubMed ID: 19609978
[TBL] [Abstract][Full Text] [Related]
26. Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN.
Gijzen K; Raymakers RA; Broers KM; Figdor CG; Torensma R
Exp Hematol; 2008 Jul; 36(7):860-70. PubMed ID: 18375037
[TBL] [Abstract][Full Text] [Related]
27. Chimpanzee pathogenic strains of HIV type 1.
Prince AM
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1259. PubMed ID: 9339841
[No Abstract] [Full Text] [Related]
28. HIV-1 step study.
Dalgleish A; Stebbing J
Lancet; 2009 Mar; 373(9666):805; author reply 806. PubMed ID: 19269507
[No Abstract] [Full Text] [Related]
29. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
30. Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine.
García-Piñeres AJ; Hildesheim A; Trivett M; Williams M; Wu L; Kewalramani VN; Pinto LA
Eur J Immunol; 2006 Feb; 36(2):437-45. PubMed ID: 16385626
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic vaccines for preventing AIDS: their use with HAART.
Hoff R; McNamara J
Lancet; 1999 May; 353(9166):1723-4. PubMed ID: 10347978
[No Abstract] [Full Text] [Related]
32. Regulated recruitment of DC-SIGN to cell-cell contact regions during zymosan-induced human dendritic cell aggregation.
de la Rosa G; Yáñez-Mó M; Samaneigo R; Serrano-Gómez D; Martínez-Muñoz L; Fernández-Ruiz E; Longo N; Sánchez-Madrid F; Corbí AL; Sánchez-Mateos P
J Leukoc Biol; 2005 May; 77(5):699-709. PubMed ID: 15728245
[TBL] [Abstract][Full Text] [Related]
33. Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.
Belyakov IM; Kuznetsov VA; Kelsall B; Klinman D; Moniuszko M; Lemon M; Markham PD; Pal R; Clements JD; Lewis MG; Strober W; Franchini G; Berzofsky JA
Blood; 2006 Apr; 107(8):3258-64. PubMed ID: 16373659
[TBL] [Abstract][Full Text] [Related]
34. Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice.
Kawamura M; Wang X; Uto T; Sato K; Ueno M; Akagi T; Hiraishi K; Matsuyama T; Akashi M; Baba M
J Med Virol; 2005 May; 76(1):7-15. PubMed ID: 15778965
[TBL] [Abstract][Full Text] [Related]
35. Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120.
Lekkerkerker AN; Ludwig IS; van Vliet SJ; van Kooyk Y; Geijtenbeek TB
Virology; 2004 Nov; 329(2):465-76. PubMed ID: 15518824
[TBL] [Abstract][Full Text] [Related]
36. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
Calarota SA; Weiner DB; Lori F; Lisziewicz J
Vaccine; 2007 Apr; 25(16):3070-4. PubMed ID: 17292518
[TBL] [Abstract][Full Text] [Related]
37. The rational design of an AIDS vaccine.
Douek DC; Kwong PD; Nabel GJ
Cell; 2006 Feb; 124(4):677-81. PubMed ID: 16497577
[TBL] [Abstract][Full Text] [Related]
38. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
[TBL] [Abstract][Full Text] [Related]
40. Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression.
Nabatov AA; van Montfort T; Geijtenbeek TB; Pollakis G; Paxton WA
FEBS J; 2006 Nov; 273(21):4944-58. PubMed ID: 17010165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
